SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NPSP NPS Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?


To: mopgcw who wrote (181)11/19/2003 6:45:31 PM
From: Miljenko Zuanic  Read Replies (2) | Respond to of 363
 
Does this sound like trouble????

Press Release Source: NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals to Report Results of PREOS Carcinogenicity Study
Wednesday November 19, 4:30 pm ET

SALT LAKE CITY, Nov. 19 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP - News) announced today that it will report on Thursday, November 20, 2003 at 8:00 a.m. EST (6:00 a.m. MST) preliminary results from a two-year rat carcinogenicity study of PREOS®, its proprietary full-length human parathyroid hormone (PTH) drug candidate being developed for the treatment of osteoporosis. The report will comprise a press release, and a conference call and webcast featuring Dr. Hunter Jackson, Chairman, CEO, and President, and other members of the NPS senior management team.
(Logo: newscom.com )
To participate in the conference call, dial (800) 374-0232 and use confirmation code 4120937. International callers may dial (706) 634-6338, using the same confirmation code. In addition, live audio of the conference call will be simultaneously broadcast over the Internet and may be accessed on the company's web site ( www.npsp.com ). Please click on the webcast link and follow the prompts for registration and access.

If you are unable to participate in the live call, a replay will be available at (800) 642-1687 (with confirmation code 4120937) until midnight, EST, November 27, 2003. International callers may access the replay by dialing (706) 645-9291, using the same confirmation code. The webcast portion of the call will also be available on the NPS website for the same period of time.